JP2008001643A - Horny plug-removing facial cleansing agent - Google Patents
Horny plug-removing facial cleansing agent Download PDFInfo
- Publication number
- JP2008001643A JP2008001643A JP2006173218A JP2006173218A JP2008001643A JP 2008001643 A JP2008001643 A JP 2008001643A JP 2006173218 A JP2006173218 A JP 2006173218A JP 2006173218 A JP2006173218 A JP 2006173218A JP 2008001643 A JP2008001643 A JP 2008001643A
- Authority
- JP
- Japan
- Prior art keywords
- face wash
- plug
- spherical
- cleansing agent
- facial cleansing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000001815 facial effect Effects 0.000 title abstract description 23
- 239000003599 detergent Substances 0.000 title abstract description 8
- -1 polyethylene Polymers 0.000 claims abstract description 35
- 239000000843 powder Substances 0.000 claims abstract description 31
- 235000014113 dietary fatty acids Nutrition 0.000 claims abstract description 23
- 239000000194 fatty acid Substances 0.000 claims abstract description 23
- 229930195729 fatty acid Natural products 0.000 claims abstract description 23
- 229920006037 cross link polymer Polymers 0.000 claims abstract description 20
- 239000002245 particle Substances 0.000 claims abstract description 19
- 150000004665 fatty acids Chemical class 0.000 claims abstract description 15
- 239000000344 soap Substances 0.000 claims abstract description 15
- 239000004698 Polyethylene Substances 0.000 claims abstract description 9
- 229920000573 polyethylene Polymers 0.000 claims abstract description 9
- 150000005690 diesters Chemical class 0.000 claims abstract description 8
- 239000002253 acid Substances 0.000 claims abstract description 6
- 239000004205 dimethyl polysiloxane Substances 0.000 claims description 17
- 235000013870 dimethyl polysiloxane Nutrition 0.000 claims description 17
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 claims description 17
- 229940008099 dimethicone Drugs 0.000 claims description 16
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 claims description 16
- 229920002554 vinyl polymer Polymers 0.000 claims description 16
- 238000005406 washing Methods 0.000 claims description 6
- 125000004432 carbon atom Chemical group C* 0.000 claims description 4
- 238000004140 cleaning Methods 0.000 claims description 3
- 239000002537 cosmetic Substances 0.000 abstract description 9
- 230000007794 irritation Effects 0.000 abstract description 6
- 229920001296 polysiloxane Polymers 0.000 description 16
- 230000000694 effects Effects 0.000 description 14
- 238000000034 method Methods 0.000 description 14
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 13
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 9
- 239000006260 foam Substances 0.000 description 9
- 239000011148 porous material Substances 0.000 description 9
- 229920001971 elastomer Polymers 0.000 description 8
- 239000006096 absorbing agent Substances 0.000 description 7
- 239000004359 castor oil Substances 0.000 description 7
- 235000019438 castor oil Nutrition 0.000 description 7
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 7
- 150000002632 lipids Chemical class 0.000 description 7
- 238000012360 testing method Methods 0.000 description 7
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 6
- 238000005187 foaming Methods 0.000 description 6
- 235000011187 glycerol Nutrition 0.000 description 6
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- DNIAPMSPPWPWGF-UHFFFAOYSA-N monopropylene glycol Natural products CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 5
- 239000003921 oil Substances 0.000 description 5
- 235000019198 oils Nutrition 0.000 description 5
- 239000011591 potassium Substances 0.000 description 5
- 229910052700 potassium Inorganic materials 0.000 description 5
- 239000007787 solid Substances 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 102000011782 Keratins Human genes 0.000 description 4
- 108010076876 Keratins Proteins 0.000 description 4
- 239000004166 Lanolin Substances 0.000 description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 238000009826 distribution Methods 0.000 description 4
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 4
- 238000009472 formulation Methods 0.000 description 4
- 235000019388 lanolin Nutrition 0.000 description 4
- 229940039717 lanolin Drugs 0.000 description 4
- 239000002280 amphoteric surfactant Substances 0.000 description 3
- 239000011324 bead Substances 0.000 description 3
- 230000000052 comparative effect Effects 0.000 description 3
- 239000002552 dosage form Substances 0.000 description 3
- 230000001771 impaired effect Effects 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 210000004761 scalp Anatomy 0.000 description 3
- 210000003491 skin Anatomy 0.000 description 3
- 210000000434 stratum corneum Anatomy 0.000 description 3
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- DSEKYWAQQVUQTP-XEWMWGOFSA-N (2r,4r,4as,6as,6as,6br,8ar,12ar,14as,14bs)-2-hydroxy-4,4a,6a,6b,8a,11,11,14a-octamethyl-2,4,5,6,6a,7,8,9,10,12,12a,13,14,14b-tetradecahydro-1h-picen-3-one Chemical compound C([C@H]1[C@]2(C)CC[C@@]34C)C(C)(C)CC[C@]1(C)CC[C@]2(C)[C@H]4CC[C@@]1(C)[C@H]3C[C@@H](O)C(=O)[C@@H]1C DSEKYWAQQVUQTP-XEWMWGOFSA-N 0.000 description 2
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
- XDOFQFKRPWOURC-UHFFFAOYSA-N 16-methylheptadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCCCC(O)=O XDOFQFKRPWOURC-UHFFFAOYSA-N 0.000 description 2
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- 239000004386 Erythritol Substances 0.000 description 2
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 239000005639 Lauric acid Substances 0.000 description 2
- OFBQJSOFQDEBGM-UHFFFAOYSA-N Pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- 229920001214 Polysorbate 60 Polymers 0.000 description 2
- 235000021355 Stearic acid Nutrition 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 206010000496 acne Diseases 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 150000005215 alkyl ethers Chemical class 0.000 description 2
- 125000000217 alkyl group Chemical group 0.000 description 2
- 239000003945 anionic surfactant Substances 0.000 description 2
- RWZYAGGXGHYGMB-UHFFFAOYSA-N anthranilic acid Chemical compound NC1=CC=CC=C1C(O)=O RWZYAGGXGHYGMB-UHFFFAOYSA-N 0.000 description 2
- TZCXTZWJZNENPQ-UHFFFAOYSA-L barium sulfate Chemical compound [Ba+2].[O-]S([O-])(=O)=O TZCXTZWJZNENPQ-UHFFFAOYSA-L 0.000 description 2
- 239000011538 cleaning material Substances 0.000 description 2
- 239000003240 coconut oil Substances 0.000 description 2
- 235000019864 coconut oil Nutrition 0.000 description 2
- 229940031569 diisopropyl sebacate Drugs 0.000 description 2
- XFKBBSZEQRFVSL-UHFFFAOYSA-N dipropan-2-yl decanedioate Chemical compound CC(C)OC(=O)CCCCCCCCC(=O)OC(C)C XFKBBSZEQRFVSL-UHFFFAOYSA-N 0.000 description 2
- NOPFSRXAKWQILS-UHFFFAOYSA-N docosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCO NOPFSRXAKWQILS-UHFFFAOYSA-N 0.000 description 2
- UKMSUNONTOPOIO-UHFFFAOYSA-N docosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCC(O)=O UKMSUNONTOPOIO-UHFFFAOYSA-N 0.000 description 2
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 2
- 235000019414 erythritol Nutrition 0.000 description 2
- 229940009714 erythritol Drugs 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 2
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- 229940119170 jojoba wax Drugs 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000010445 mica Substances 0.000 description 2
- 229910052618 mica group Inorganic materials 0.000 description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- XOJVVFBFDXDTEG-UHFFFAOYSA-N pristane Chemical compound CC(C)CCCC(C)CCCC(C)CCCC(C)C XOJVVFBFDXDTEG-UHFFFAOYSA-N 0.000 description 2
- 229960004063 propylene glycol Drugs 0.000 description 2
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 description 2
- MMXZSJMASHPLLR-UHFFFAOYSA-N pyrroloquinoline quinone Chemical compound C12=C(C(O)=O)C=C(C(O)=O)N=C2C(=O)C(=O)C2=C1NC(C(=O)O)=C2 MMXZSJMASHPLLR-UHFFFAOYSA-N 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 238000007790 scraping Methods 0.000 description 2
- 238000005201 scrubbing Methods 0.000 description 2
- CXMXRPHRNRROMY-UHFFFAOYSA-N sebacic acid Chemical compound OC(=O)CCCCCCCCC(O)=O CXMXRPHRNRROMY-UHFFFAOYSA-N 0.000 description 2
- 239000000377 silicon dioxide Substances 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 241000894007 species Species 0.000 description 2
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 2
- 239000008117 stearic acid Substances 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- HLZKNKRTKFSKGZ-UHFFFAOYSA-N tetradecan-1-ol Chemical compound CCCCCCCCCCCCCCO HLZKNKRTKFSKGZ-UHFFFAOYSA-N 0.000 description 2
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 2
- 239000001993 wax Substances 0.000 description 2
- WGVKWNUPNGFDFJ-DQCZWYHMSA-N β-tocopherol Chemical compound OC1=CC(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C WGVKWNUPNGFDFJ-DQCZWYHMSA-N 0.000 description 2
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 1
- CUNWUEBNSZSNRX-RKGWDQTMSA-N (2r,3r,4r,5s)-hexane-1,2,3,4,5,6-hexol;(z)-octadec-9-enoic acid Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O CUNWUEBNSZSNRX-RKGWDQTMSA-N 0.000 description 1
- BJDAUCLANVMIOB-UHFFFAOYSA-N (3-decanoyloxy-2,2-dimethylpropyl) decanoate Chemical compound CCCCCCCCCC(=O)OCC(C)(C)COC(=O)CCCCCCCCC BJDAUCLANVMIOB-UHFFFAOYSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N (R)-alpha-Tocopherol Natural products OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
- PSBDWGZCVUAZQS-UHFFFAOYSA-N (dimethylsulfonio)acetate Chemical compound C[S+](C)CC([O-])=O PSBDWGZCVUAZQS-UHFFFAOYSA-N 0.000 description 1
- WBYWAXJHAXSJNI-VOTSOKGWSA-M .beta-Phenylacrylic acid Natural products [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 description 1
- ZORQXIQZAOLNGE-UHFFFAOYSA-N 1,1-difluorocyclohexane Chemical compound FC1(F)CCCCC1 ZORQXIQZAOLNGE-UHFFFAOYSA-N 0.000 description 1
- 229940031723 1,2-octanediol Drugs 0.000 description 1
- 229940058015 1,3-butylene glycol Drugs 0.000 description 1
- FRPZMMHWLSIFAZ-UHFFFAOYSA-N 10-undecenoic acid Chemical compound OC(=O)CCCCCCCCC=C FRPZMMHWLSIFAZ-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- RKJGFHYCZPZJPE-UHFFFAOYSA-N 2,2-bis(16-methylheptadecanoyloxymethyl)butyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(CC)(COC(=O)CCCCCCCCCCCCCCC(C)C)COC(=O)CCCCCCCCCCCCCCC(C)C RKJGFHYCZPZJPE-UHFFFAOYSA-N 0.000 description 1
- XFOQWQKDSMIPHT-UHFFFAOYSA-N 2,3-dichloro-6-(trifluoromethyl)pyridine Chemical compound FC(F)(F)C1=CC=C(Cl)C(Cl)=N1 XFOQWQKDSMIPHT-UHFFFAOYSA-N 0.000 description 1
- FKOKUHFZNIUSLW-UHFFFAOYSA-N 2-Hydroxypropyl stearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(C)O FKOKUHFZNIUSLW-UHFFFAOYSA-N 0.000 description 1
- NCLNAHJFXIKYBY-UHFFFAOYSA-N 2-hexyldecyl 16-methylheptadecanoate Chemical compound CCCCCCCCC(CCCCCC)COC(=O)CCCCCCCCCCCCCCC(C)C NCLNAHJFXIKYBY-UHFFFAOYSA-N 0.000 description 1
- MUHFRORXWCGZGE-KTKRTIGZSA-N 2-hydroxyethyl (z)-octadec-9-enoate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCCO MUHFRORXWCGZGE-KTKRTIGZSA-N 0.000 description 1
- LEACJMVNYZDSKR-UHFFFAOYSA-N 2-octyldodecan-1-ol Chemical compound CCCCCCCCCCC(CO)CCCCCCCC LEACJMVNYZDSKR-UHFFFAOYSA-N 0.000 description 1
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- XPFCZYUVICHKDS-UHFFFAOYSA-N 3-methylbutane-1,3-diol Chemical compound CC(C)(O)CCO XPFCZYUVICHKDS-UHFFFAOYSA-N 0.000 description 1
- CYDQOEWLBCCFJZ-UHFFFAOYSA-N 4-(4-fluorophenyl)oxane-4-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1(C(=O)O)CCOCC1 CYDQOEWLBCCFJZ-UHFFFAOYSA-N 0.000 description 1
- HBTAOSGHCXUEKI-UHFFFAOYSA-N 4-chloro-n,n-dimethyl-3-nitrobenzenesulfonamide Chemical compound CN(C)S(=O)(=O)C1=CC=C(Cl)C([N+]([O-])=O)=C1 HBTAOSGHCXUEKI-UHFFFAOYSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 201000004384 Alopecia Diseases 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- 235000021357 Behenic acid Nutrition 0.000 description 1
- 235000014698 Brassica juncea var multisecta Nutrition 0.000 description 1
- 235000006008 Brassica napus var napus Nutrition 0.000 description 1
- 235000006618 Brassica rapa subsp oleifera Nutrition 0.000 description 1
- 244000188595 Brassica sinapistrum Species 0.000 description 1
- 235000004977 Brassica sinapistrum Nutrition 0.000 description 1
- SGHZXLIDFTYFHQ-UHFFFAOYSA-L Brilliant Blue Chemical compound [Na+].[Na+].C=1C=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C(=CC=CC=2)S([O-])(=O)=O)C=CC=1N(CC)CC1=CC=CC(S([O-])(=O)=O)=C1 SGHZXLIDFTYFHQ-UHFFFAOYSA-L 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- WBYWAXJHAXSJNI-SREVYHEPSA-N Cinnamic acid Chemical compound OC(=O)\C=C/C1=CC=CC=C1 WBYWAXJHAXSJNI-SREVYHEPSA-N 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- VIZORQUEIQEFRT-UHFFFAOYSA-N Diethyl adipate Chemical compound CCOC(=O)CCCCC(=O)OCC VIZORQUEIQEFRT-UHFFFAOYSA-N 0.000 description 1
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical class [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 description 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
- 239000005977 Ethylene Substances 0.000 description 1
- 229940124091 Keratolytic Drugs 0.000 description 1
- 235000018330 Macadamia integrifolia Nutrition 0.000 description 1
- 240000000912 Macadamia tetraphylla Species 0.000 description 1
- 235000003800 Macadamia tetraphylla Nutrition 0.000 description 1
- BACYUWVYYTXETD-UHFFFAOYSA-N N-Lauroylsarcosine Chemical compound CCCCCCCCCCCC(=O)N(C)CC(O)=O BACYUWVYYTXETD-UHFFFAOYSA-N 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 235000019482 Palm oil Nutrition 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- RVSTWRHIGKXTLG-UHFFFAOYSA-N Pangamic acid Natural products CC(C)N(C(C)C)C(N(C(C)C)C(C)C)C(=O)OCC(O)C(O)C(O)C(O)C(O)=O RVSTWRHIGKXTLG-UHFFFAOYSA-N 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 235000019484 Rapeseed oil Nutrition 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- 235000019485 Safflower oil Nutrition 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical group [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 1
- VBIIFPGSPJYLRR-UHFFFAOYSA-M Stearyltrimethylammonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCC[N+](C)(C)C VBIIFPGSPJYLRR-UHFFFAOYSA-M 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 229920002359 Tetronic® Polymers 0.000 description 1
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- ZJCCRDAZUWHFQH-UHFFFAOYSA-N Trimethylolpropane Chemical compound CCC(CO)(CO)CO ZJCCRDAZUWHFQH-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 229930003779 Vitamin B12 Natural products 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- LXNHXLLTXMVWPM-UHFFFAOYSA-N Vitamin B6 Natural products CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 1
- 229930003756 Vitamin B7 Natural products 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- UDRYFKCHZFVZGJ-UHFFFAOYSA-N [5-hexadecanoyloxy-4-(hexadecanoyloxymethyl)-6-methylpyridin-3-yl]methyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC1=CN=C(C)C(OC(=O)CCCCCCCCCCCCCCC)=C1COC(=O)CCCCCCCCCCCCCCC UDRYFKCHZFVZGJ-UHFFFAOYSA-N 0.000 description 1
- RJDOZRNNYVAULJ-UHFFFAOYSA-L [O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[F-].[F-].[Mg++].[Mg++].[Mg++].[Al+3].[Si+4].[Si+4].[Si+4].[K+] Chemical compound [O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[F-].[F-].[Mg++].[Mg++].[Mg++].[Al+3].[Si+4].[Si+4].[Si+4].[K+] RJDOZRNNYVAULJ-UHFFFAOYSA-L 0.000 description 1
- 238000005299 abrasion Methods 0.000 description 1
- 239000003463 adsorbent Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 150000004347 all-trans-retinol derivatives Chemical class 0.000 description 1
- 229940061720 alpha hydroxy acid Drugs 0.000 description 1
- 150000001280 alpha hydroxy acids Chemical class 0.000 description 1
- 229940087168 alpha tocopherol Drugs 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 210000003484 anatomy Anatomy 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- BTFJIXJJCSYFAL-UHFFFAOYSA-N arachidyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCO BTFJIXJJCSYFAL-UHFFFAOYSA-N 0.000 description 1
- 239000010426 asphalt Substances 0.000 description 1
- 235000021302 avocado oil Nutrition 0.000 description 1
- 239000008163 avocado oil Substances 0.000 description 1
- IRERQBUNZFJFGC-UHFFFAOYSA-L azure blue Chemical compound [Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[S-]S[S-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-] IRERQBUNZFJFGC-UHFFFAOYSA-L 0.000 description 1
- POJOORKDYOPQLS-UHFFFAOYSA-L barium(2+) 5-chloro-2-[(2-hydroxynaphthalen-1-yl)diazenyl]-4-methylbenzenesulfonate Chemical compound [Ba+2].C1=C(Cl)C(C)=CC(N=NC=2C3=CC=CC=C3C=CC=2O)=C1S([O-])(=O)=O.C1=C(Cl)C(C)=CC(N=NC=2C3=CC=CC=C3C=CC=2O)=C1S([O-])(=O)=O POJOORKDYOPQLS-UHFFFAOYSA-L 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 229940116226 behenic acid Drugs 0.000 description 1
- 229960000686 benzalkonium chloride Drugs 0.000 description 1
- RWCCWEUUXYIKHB-UHFFFAOYSA-N benzophenone Chemical compound C=1C=CC=CC=1C(=O)C1=CC=CC=C1 RWCCWEUUXYIKHB-UHFFFAOYSA-N 0.000 description 1
- 239000012965 benzophenone Substances 0.000 description 1
- QRUDEWIWKLJBPS-UHFFFAOYSA-N benzotriazole Chemical compound C1=CC=C2N[N][N]C2=C1 QRUDEWIWKLJBPS-UHFFFAOYSA-N 0.000 description 1
- 239000012964 benzotriazole Substances 0.000 description 1
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 1
- 229940066595 beta tocopherol Drugs 0.000 description 1
- 229960003237 betaine Drugs 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- HGKOWIQVWAQWDS-UHFFFAOYSA-N bis(16-methylheptadecyl) 2-hydroxybutanedioate Chemical compound CC(C)CCCCCCCCCCCCCCCOC(=O)CC(O)C(=O)OCCCCCCCCCCCCCCCC(C)C HGKOWIQVWAQWDS-UHFFFAOYSA-N 0.000 description 1
- 229940073609 bismuth oxychloride Drugs 0.000 description 1
- DBZJJPROPLPMSN-UHFFFAOYSA-N bromoeosin Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC(Br)=C(O)C(Br)=C1OC1=C(Br)C(O)=C(Br)C=C21 DBZJJPROPLPMSN-UHFFFAOYSA-N 0.000 description 1
- 235000019437 butane-1,3-diol Nutrition 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- KHAVLLBUVKBTBG-UHFFFAOYSA-N caproleic acid Natural products OC(=O)CCCCCCCC=C KHAVLLBUVKBTBG-UHFFFAOYSA-N 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 239000004203 carnauba wax Substances 0.000 description 1
- 235000013869 carnauba wax Nutrition 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- 229940082500 cetostearyl alcohol Drugs 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 229930016911 cinnamic acid Natural products 0.000 description 1
- 235000013985 cinnamic acid Nutrition 0.000 description 1
- 239000012459 cleaning agent Substances 0.000 description 1
- 229910000428 cobalt oxide Inorganic materials 0.000 description 1
- AGVAZMGAQJOSFJ-WZHZPDAFSA-M cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].N#[C-].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP(O)(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O AGVAZMGAQJOSFJ-WZHZPDAFSA-M 0.000 description 1
- IVMYJDGYRUAWML-UHFFFAOYSA-N cobalt(ii) oxide Chemical compound [Co]=O IVMYJDGYRUAWML-UHFFFAOYSA-N 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000007799 cork Substances 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 235000012343 cottonseed oil Nutrition 0.000 description 1
- 239000002385 cottonseed oil Substances 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- YSAVZVORKRDODB-WDSKDSINSA-N diethyl tartrate Chemical compound CCOC(=O)[C@@H](O)[C@H](O)C(=O)OCC YSAVZVORKRDODB-WDSKDSINSA-N 0.000 description 1
- 229940105990 diglycerin Drugs 0.000 description 1
- GPLRAVKSCUXZTP-UHFFFAOYSA-N diglycerol Chemical compound OCC(O)COCC(O)CO GPLRAVKSCUXZTP-UHFFFAOYSA-N 0.000 description 1
- 229940031578 diisopropyl adipate Drugs 0.000 description 1
- XEBCWEDRGPSHQH-UHFFFAOYSA-N diisopropyl tartrate Chemical compound CC(C)OC(=O)C(O)C(O)C(=O)OC(C)C XEBCWEDRGPSHQH-UHFFFAOYSA-N 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- 229940113120 dipropylene glycol Drugs 0.000 description 1
- VPWFPZBFBFHIIL-UHFFFAOYSA-L disodium 4-[(4-methyl-2-sulfophenyl)diazenyl]-3-oxidonaphthalene-2-carboxylate Chemical compound [Na+].[Na+].[O-]S(=O)(=O)C1=CC(C)=CC=C1N=NC1=C(O)C(C([O-])=O)=CC2=CC=CC=C12 VPWFPZBFBFHIIL-UHFFFAOYSA-L 0.000 description 1
- FHRUGNCCGSEPPE-UHFFFAOYSA-L disodium;2-(4,5-dibromo-3,6-dioxido-9h-xanthen-9-yl)benzoate;hydron Chemical compound [H+].[Na+].[Na+].[O-]C(=O)C1=CC=CC=C1C1C2=CC=C([O-])C(Br)=C2OC2=C(Br)C([O-])=CC=C21 FHRUGNCCGSEPPE-UHFFFAOYSA-L 0.000 description 1
- FPAYXBWMYIMERV-UHFFFAOYSA-L disodium;5-methyl-2-[[4-(4-methyl-2-sulfonatoanilino)-9,10-dioxoanthracen-1-yl]amino]benzenesulfonate Chemical compound [Na+].[Na+].[O-]S(=O)(=O)C1=CC(C)=CC=C1NC(C=1C(=O)C2=CC=CC=C2C(=O)C=11)=CC=C1NC1=CC=C(C)C=C1S([O-])(=O)=O FPAYXBWMYIMERV-UHFFFAOYSA-L 0.000 description 1
- 229960000735 docosanol Drugs 0.000 description 1
- SYELZBGXAIXKHU-UHFFFAOYSA-N dodecyldimethylamine N-oxide Chemical compound CCCCCCCCCCCC[N+](C)(C)[O-] SYELZBGXAIXKHU-UHFFFAOYSA-N 0.000 description 1
- 235000006694 eating habits Nutrition 0.000 description 1
- 239000000806 elastomer Substances 0.000 description 1
- 239000010696 ester oil Substances 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 210000000416 exudates and transudate Anatomy 0.000 description 1
- 239000011888 foil Substances 0.000 description 1
- 235000010382 gamma-tocopherol Nutrition 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 229960005150 glycerol Drugs 0.000 description 1
- 229940075507 glyceryl monostearate Drugs 0.000 description 1
- 230000003676 hair loss Effects 0.000 description 1
- OIKBVOIOVNEVJR-UHFFFAOYSA-N hexadecyl 6-methylheptanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)CCCCC(C)C OIKBVOIOVNEVJR-UHFFFAOYSA-N 0.000 description 1
- TXGJTWACJNYNOJ-UHFFFAOYSA-N hexane-2,4-diol Chemical compound CCC(O)CC(C)O TXGJTWACJNYNOJ-UHFFFAOYSA-N 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- MTNDZQHUAFNZQY-UHFFFAOYSA-N imidazoline Chemical compound C1CN=CN1 MTNDZQHUAFNZQY-UHFFFAOYSA-N 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 229910010272 inorganic material Inorganic materials 0.000 description 1
- 239000011147 inorganic material Substances 0.000 description 1
- 239000001023 inorganic pigment Substances 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- WTFXARWRTYJXII-UHFFFAOYSA-N iron(2+);iron(3+);oxygen(2-) Chemical compound [O-2].[O-2].[O-2].[O-2].[Fe+2].[Fe+3].[Fe+3] WTFXARWRTYJXII-UHFFFAOYSA-N 0.000 description 1
- SZVJSHCCFOBDDC-UHFFFAOYSA-N iron(II,III) oxide Inorganic materials O=[Fe]O[Fe]O[Fe]=O SZVJSHCCFOBDDC-UHFFFAOYSA-N 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 230000001530 keratinolytic effect Effects 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 229960000448 lactic acid Drugs 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
- 239000001095 magnesium carbonate Substances 0.000 description 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
- 239000000845 maltitol Substances 0.000 description 1
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 1
- 235000010449 maltitol Nutrition 0.000 description 1
- 229940035436 maltitol Drugs 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- WBYWAXJHAXSJNI-UHFFFAOYSA-N methyl p-hydroxycinnamate Natural products OC(=O)C=CC1=CC=CC=C1 WBYWAXJHAXSJNI-UHFFFAOYSA-N 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000004200 microcrystalline wax Substances 0.000 description 1
- 235000019808 microcrystalline wax Nutrition 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 1
- 229940043348 myristyl alcohol Drugs 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- GSGDTSDELPUTKU-UHFFFAOYSA-N nonoxybenzene Chemical compound CCCCCCCCCOC1=CC=CC=C1 GSGDTSDELPUTKU-UHFFFAOYSA-N 0.000 description 1
- 239000010466 nut oil Substances 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- KSCKTBJJRVPGKM-UHFFFAOYSA-N octan-1-olate;titanium(4+) Chemical compound [Ti+4].CCCCCCCC[O-].CCCCCCCC[O-].CCCCCCCC[O-].CCCCCCCC[O-] KSCKTBJJRVPGKM-UHFFFAOYSA-N 0.000 description 1
- AEIJTFQOBWATKX-UHFFFAOYSA-N octane-1,2-diol Chemical compound CCCCCCC(O)CO AEIJTFQOBWATKX-UHFFFAOYSA-N 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- TWNQGVIAIRXVLR-UHFFFAOYSA-N oxo(oxoalumanyloxy)alumane Chemical compound O=[Al]O[Al]=O TWNQGVIAIRXVLR-UHFFFAOYSA-N 0.000 description 1
- BWOROQSFKKODDR-UHFFFAOYSA-N oxobismuth;hydrochloride Chemical compound Cl.[Bi]=O BWOROQSFKKODDR-UHFFFAOYSA-N 0.000 description 1
- 239000002540 palm oil Substances 0.000 description 1
- ZQTHOIGMSJMBLM-BUJSFMDZSA-N pangamic acid Chemical compound CN(C)CC(=O)OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O ZQTHOIGMSJMBLM-BUJSFMDZSA-N 0.000 description 1
- 108700024047 pangamic acid Proteins 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 description 1
- 229940066842 petrolatum Drugs 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 229960005323 phenoxyethanol Drugs 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 229920001983 poloxamer Polymers 0.000 description 1
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 1
- 239000004926 polymethyl methacrylate Substances 0.000 description 1
- 239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 description 1
- 235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 description 1
- ONQDVAFWWYYXHM-UHFFFAOYSA-M potassium lauryl sulfate Chemical compound [K+].CCCCCCCCCCCCOS([O-])(=O)=O ONQDVAFWWYYXHM-UHFFFAOYSA-M 0.000 description 1
- 229940116985 potassium lauryl sulfate Drugs 0.000 description 1
- 235000013772 propylene glycol Nutrition 0.000 description 1
- 229940093625 propylene glycol monostearate Drugs 0.000 description 1
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- PYWVYCXTNDRMGF-UHFFFAOYSA-N rhodamine B Chemical compound [Cl-].C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=CC=C1C(O)=O PYWVYCXTNDRMGF-UHFFFAOYSA-N 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 235000005713 safflower oil Nutrition 0.000 description 1
- 239000003813 safflower oil Substances 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 108700004121 sarkosyl Proteins 0.000 description 1
- 210000002374 sebum Anatomy 0.000 description 1
- 230000009291 secondary effect Effects 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- 238000007873 sieving Methods 0.000 description 1
- RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 229920002379 silicone rubber Polymers 0.000 description 1
- 239000004945 silicone rubber Substances 0.000 description 1
- 239000008149 soap solution Substances 0.000 description 1
- 239000001540 sodium lactate Substances 0.000 description 1
- 235000011088 sodium lactate Nutrition 0.000 description 1
- 229940005581 sodium lactate Drugs 0.000 description 1
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 1
- 229940045920 sodium pyrrolidone carboxylate Drugs 0.000 description 1
- HYRLWUFWDYFEES-UHFFFAOYSA-M sodium;2-oxopyrrolidine-1-carboxylate Chemical compound [Na+].[O-]C(=O)N1CCCC1=O HYRLWUFWDYFEES-UHFFFAOYSA-M 0.000 description 1
- 239000007779 soft material Substances 0.000 description 1
- 239000001593 sorbitan monooleate Substances 0.000 description 1
- 235000011069 sorbitan monooleate Nutrition 0.000 description 1
- 229940035049 sorbitan monooleate Drugs 0.000 description 1
- 239000001587 sorbitan monostearate Substances 0.000 description 1
- 235000011076 sorbitan monostearate Nutrition 0.000 description 1
- 229940035048 sorbitan monostearate Drugs 0.000 description 1
- 229960005078 sorbitan sesquioleate Drugs 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 235000010356 sorbitol Nutrition 0.000 description 1
- 229940032094 squalane Drugs 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 229940117986 sulfobetaine Drugs 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 1
- 229960000984 tocofersolan Drugs 0.000 description 1
- AOBORMOPSGHCAX-DGHZZKTQSA-N tocofersolan Chemical compound OCCOC(=O)CCC(=O)OC1=C(C)C(C)=C2O[C@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C AOBORMOPSGHCAX-DGHZZKTQSA-N 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- 229940118594 trimethylolpropane triisostearate Drugs 0.000 description 1
- UJMBCXLDXJUMFB-UHFFFAOYSA-K trisodium;5-oxo-1-(4-sulfonatophenyl)-4-[(4-sulfonatophenyl)diazenyl]-4h-pyrazole-3-carboxylate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)C1=NN(C=2C=CC(=CC=2)S([O-])(=O)=O)C(=O)C1N=NC1=CC=C(S([O-])(=O)=O)C=C1 UJMBCXLDXJUMFB-UHFFFAOYSA-K 0.000 description 1
- 229960002703 undecylenic acid Drugs 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 235000019163 vitamin B12 Nutrition 0.000 description 1
- 239000011715 vitamin B12 Substances 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 235000019158 vitamin B6 Nutrition 0.000 description 1
- 239000011726 vitamin B6 Substances 0.000 description 1
- 235000011912 vitamin B7 Nutrition 0.000 description 1
- 239000011735 vitamin B7 Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
- 235000004835 α-tocopherol Nutrition 0.000 description 1
- 239000002076 α-tocopherol Substances 0.000 description 1
- 235000007680 β-tocopherol Nutrition 0.000 description 1
- 239000011590 β-tocopherol Substances 0.000 description 1
- 239000002478 γ-tocopherol Substances 0.000 description 1
- QUEDXNHFTDJVIY-DQCZWYHMSA-N γ-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1 QUEDXNHFTDJVIY-DQCZWYHMSA-N 0.000 description 1
Landscapes
- Cosmetics (AREA)
Abstract
Description
本発明は洗顔料に関し、更に詳細には、角栓除去作用を有する洗顔料に関する。 The present invention relates to a face wash, and more particularly, to a face wash having an action of removing a plug.
食生活が西欧化し、脂質摂取量が著しく増大した今日において、毛穴に蓄積される、特に小鼻の毛穴に蓄積される、脂質代謝産物と、角層離脱物の複合化物である、角栓の問題は一昔前に比して重大な問題となりつつある。過剰に蓄積された角栓は、そこに巣くった微生物などにより、ニキビなどの症状の原因となると言われている。小鼻に蓄積する角栓は、頭皮などに蓄積する角栓と異なり、脂質以外に角層の脱離物等、油剤などで溶解しない成分と、脂質の複合体を形成しているため、特に除去するのが困難であると言われている。又、この様な症状を呈さなくとも、黒ずんだ毛穴の存在は、その人の外観美を損なうものであるし、他人における印象形成に悪い影響を与えたりもする。この様な背景から、毛穴、特に小鼻の毛穴に形成される角栓の除去を効率的に、且つ、安全に行うための手段の開発が種々為されている。この様な手段としては、例えば、粘着性を有するシートに角栓を粘着させ、これを引きはがすことにより、除去する方法(例えば、特許文献1を参照)、ラウロイルサルコシンのエステルを利用して角栓の脂質を溶解させ吸引などの処置により除去する方法(例えば、特許文献2を参照)、塩基性の物質で擦過することにより、角層とともに角栓を溶解せしめ除去する方法(例えば、特許文献3を参照)、粘着性を有する泡沫で擦過しながら除去する方法(例えば、特許文献4を参照)、尿素やα−ヒドロキシ酸などのような角質溶解成分を含むスクラブ化粧料で、角質を溶解させながらスクラブ剤により掻き取る方法(例えば、特許文献5を参照)等が存する。特にこれらの中では、特許文献1に記載の方法が安全性高く、除去効果も高いが、吸引装置による吸引を要する。又、除去効果としては、特許文献5に記載の方法が最も高いが、擦過による刺激の発現を抑制されているとはいえ、前記4種の他の方法に比して、角栓除去に伴う刺激発現する可能性は高い。従って、特許文献5に記載の方法と同程度の角栓除去効果を有しながら、刺激発現可能性のさらに低い角栓除去用の化粧料の開発が望まれていた。特に、角栓を除去した後毛穴に残る脂質をも取り去り、面皰などの発生を予防することのできる化粧料の開発が望まれていた。 The problem of horn plugs, a complex of lipid metabolites and stratum corneum that accumulates in pores, especially in the pores of the nose, in today's dietary habits that have significantly increased lipid intake. Is becoming a serious problem compared to a long time ago. Excessive accumulated horn plugs are said to cause acne and other symptoms due to microorganisms nested in the plugs. The horn plug that accumulates in the nose differs from the horn plug that accumulates in the scalp, etc., and is especially removed because it forms a complex of lipids with components that do not dissolve in the oil, such as exudates from the stratum corneum. It is said that it is difficult to do. Even if such symptoms do not occur, the presence of dark pores impairs the appearance of the person and may adversely affect the impression formation of others. Against this background, various means have been developed for efficiently and safely removing the plugs formed in the pores, particularly the pores of the nose. Such means include, for example, a method in which a square plug is adhered to a sticky sheet and then removed by peeling it off (see, for example, Patent Document 1), and an angle is obtained using an ester of lauroyl sarcosine. A method of dissolving the lipid of the stopper and removing it by a treatment such as suction (for example, see Patent Document 2), and a method of dissolving and removing the corner plug together with the stratum corneum by rubbing with a basic substance (for example, Patent Document 3), a method of removing while rubbing with a sticky foam (for example, see Patent Document 4), and a scrub cosmetic containing a keratolytic component such as urea or α-hydroxy acid to dissolve the keratin. And a method of scraping with a scrubbing agent (for example, see Patent Document 5). Among these, the method described in Patent Document 1 is highly safe and has a high removal effect, but requires suction by a suction device. In addition, the removal effect is the highest in the method described in Patent Document 5, but it is accompanied by the removal of horn plugs, although the expression of irritation due to abrasion is suppressed. There is a high possibility of stimulating. Accordingly, it has been desired to develop a cosmetic for removing horn plugs that has the same effect as that of the method described in Patent Document 5 but has a lower possibility of irritation. In particular, there has been a demand for the development of a cosmetic that can remove the lipid remaining in the pores after removing the horn plug and prevent the occurrence of comedones.
一方、洗浄料の洗浄能力を利用して、角栓を除去する試みとしては、デキストリン粉末やコルク粉末をスクラブ素材として洗浄料に含有させ、これによりこそげ取る技術が開発されている(例えば、特許文献6を参照)。しかしながら、この技術では、角栓の除去がスクラブ素材にのみ依存しているため、自ずとその効果の限度が存した。又、頭皮の角栓に関しては、セバシン酸のジエステルを利用して頭皮の角栓を除去する技術は知られているが(例えば、特許文献7を参照)、洗顔料に二塩基酸のジエステルを配合する試みも全く為されていない。(ビニルジメチコン/メチコンシルセスキオキサン)クロスポリマーを化粧料で使用する技術も既に知られている(例えば、特許文献8を参照)が、このものを含有する洗顔料は全く知られていない。従って On the other hand, as an attempt to remove square plugs by utilizing the cleaning ability of the cleaning material, a technique has been developed in which dextrin powder or cork powder is contained in the cleaning material as a scrubbing material and scavenged by this (for example, patents) Reference 6). However, with this technique, the removal of horn plugs depends only on the scrub material, so there was a limit to its effectiveness. Regarding scalp plugs, a technique for removing scalp plugs using a diester of sebacic acid is known (see, for example, Patent Document 7). No attempt has been made to mix them. A technique of using a (vinyl dimethicone / methicone silsesquioxane) crosspolymer in cosmetics is already known (see, for example, Patent Document 8), but no facial cleanser containing this is known. Therefore
本発明は、この様な状況下為されたものであり、刺激性少なく、小鼻の角栓を除去できる化粧料を提供することを課題とする。 The present invention has been made under such circumstances, and an object of the present invention is to provide a cosmetic that is less irritating and that can remove the corner plugs of the nose.
この様な状況に鑑みて、本発明者らは、刺激性少なく、小鼻の角栓を除去できる化粧料を求めて、鋭意研究努力を重ねた結果、球状の(ビニルジメチコン/メチコンシルセスキオキサン)クロスポリマー粉末を含有する、洗顔料がその様な特性を備えていることを見いだし、発明を完成させるに至った。即ち、本発明は、以下に示す通りである。
(1)球状の(ビニルジメチコン/メチコンシルセスキオキサン)クロスポリマー粉末とを含有することを特徴とする、洗顔料。
(2)前記球状の(ビニルジメチコン/メチコンシルセスキオキサン)クロスポリマー粉末の平均粒径が30μmであることを特徴とする、(1)に記載の洗顔料。
(3)更に、炭素数6〜20の二塩基酸ジエステルを含有することを特徴とする、(1)又は(2)に記載の洗顔料。
(4)前記洗顔料は、角栓を除去する作用を有することを特徴とする、(1)〜(3)何れか1項に記載の洗顔料。
(5)更に、球状のポリエチレン粉末を含有することを特徴とする、(1)〜(4)何れか1項に記載の洗顔料。
(6)前記洗顔料に於いて、洗浄成分として、脂肪酸石鹸を含有することを特徴とする、(1)〜(5)何れか1項に記載の洗顔料。
In view of such circumstances, the present inventors have sought for cosmetics that are less irritating and capable of removing nasal horn plugs. As a result of intensive research efforts, the inventors have obtained spherical (vinyl dimethicone / methicone silsesquioxane). ) It has been found that facial cleansers containing cross-polymer powder have such properties and have completed the invention. That is, the present invention is as follows.
(1) A face wash comprising a spherical (vinyl dimethicone / methicone silsesquioxane) cross-polymer powder.
(2) The face wash according to (1), wherein the spherical (vinyl dimethicone / methicone silsesquioxane) cross-polymer powder has an average particle size of 30 μm.
(3) The face wash according to (1) or (2), further comprising a dibasic acid diester having 6 to 20 carbon atoms.
(4) The face wash according to any one of (1) to (3), wherein the face wash has an action of removing a square plug.
(5) The facial cleanser according to any one of (1) to (4), further comprising spherical polyethylene powder.
(6) The face wash according to any one of (1) to (5), wherein the face wash contains a fatty acid soap as a washing component.
本発明によれば、刺激性少なく、小鼻の角栓を除去できる化粧料を提供することができる。 ADVANTAGE OF THE INVENTION According to this invention, cosmetics with little irritation and which can remove the corner plug of a nose can be provided.
(1)本発明の洗顔料の必須成分である(ビニルジメチコン/メチコンシルセスキオキサン)クロスポリマー
本発明の洗顔料は、球状の(ビニルジメチコン/メチコンシルセスキオキサン)クロスポリマー粉末を含有することを特徴とする。ここで、本発明に於いて、球状としては、外接する真球よりプラスマイナス10%の最大歪みを許容する。本発明で言う「粉末」とは、平均粒径が100μm以下の固体を意味する。該固体は、弾性、可塑性を有していても構わない。かかる(ビニルジメチコン/メチコンシルセスキオキサン)クロスポリマーはシロキシ結合にC−C結合が混在する弾性を有する固体構造と、シリカの珪素原子の結合手の一つがメチル基である、無機性の高いシリコーンの構造とが組み合わされた形のクロスポリマーであり、平均粒径としては、1〜50μmが好ましく、5〜40μmがより好ましい。これらは唯一種を含有することもできるし、二種以上を組み合わせて含有することもできる。この様なクロスポリマーには市販品が存し、かかる市販品を購入して利用することができる。この様な市販品としては、例えば、信越化学株式会社より販売されている、「シリコーンKSP−100」(平均粒径5μm;ゴム硬度30デュロメータA)、「シリコーンKSP−101」(平均粒径12μm;ゴム硬度30デュロメータA)、「シリコーンKSP−102」(平均粒径30μm;ゴム硬度30デュロメータA)、「シリコーンKSP−105」(平均粒径2μm;ゴム硬度75デュロメータA)、「シリコーンKSP−300」(平均粒径5μm;ゴム硬度40デュロメータA)等が好適に例示できる。これらは、ゴム硬度が示すように、弾性を有した形状可変性のある固体である。この様な柔らかさが角栓を刮げ出すのに好ましい。特に30デュロメータA前後の比較的柔らかいものが特に好ましい。市販品の内、特に好ましいものは「シリコーンKSP−102」である。これは、この粒径のものが、皮脂の吸着体となると同時に、刺激感の極めて少ないスクラブ剤ともなるからである。又、驚くべきことに、洗顔料に於いては、かかる成分は泡質を肌理の細かい、こしのあるものに改善する副次的作用も有する。本発明の洗顔料では、この2つの機能を同時に発現する。かかる成分の好ましい含有量は、総量で洗顔料全量に対して、1〜5質量%含有することが好ましく、1.5〜3質量%含有することがより好ましい。
(1) (Vinyl Dimethicone / Methicone Silsesquioxane) Cross Polymer which is an Essential Component of the Face Wash of the Present Invention The face wash of the present invention contains a spherical (vinyl dimethicone / methicone silsesquioxane) cross polymer powder. It is characterized by that. In the present invention, the spherical shape allows a maximum strain of plus or minus 10% from the circumscribed true sphere. The “powder” referred to in the present invention means a solid having an average particle size of 100 μm or less. The solid may have elasticity and plasticity. Such a (vinyl dimethicone / methicone silsesquioxane) cross polymer is a highly inorganic material having a solid structure having elasticity in which a C—C bond is mixed with a siloxy bond, and one of the silicon atoms of silica is a methyl group. It is a cross polymer in a form combined with a silicone structure, and the average particle diameter is preferably 1 to 50 μm, more preferably 5 to 40 μm. These can contain only the seed | species, and can also contain it in combination of 2 or more type. Such cross-polymers have commercial products, and such commercial products can be purchased and used. Examples of such commercially available products include “silicone KSP-100” (average particle size 5 μm; rubber hardness 30 durometer A) and “silicone KSP-101” (average particle size 12 μm) sold by Shin-Etsu Chemical Co., Ltd. Rubber hardness 30 durometer A), “silicone KSP-102” (average particle size 30 μm; rubber hardness 30 durometer A), “silicone KSP-105” (average particle size 2 μm; rubber hardness 75 durometer A), “silicone KSP- 300 ”(average particle size 5 μm; rubber hardness 40 durometer A) can be suitably exemplified. These are solids having elasticity and elasticity as indicated by the rubber hardness. Such softness is preferable for baldness. In particular, a relatively soft material of around 30 durometer A is particularly preferable. Among the commercially available products, “silicone KSP-102” is particularly preferable. This is because a particle having this particle size becomes a sebum adsorbent and at the same time a scrub agent with very little irritation. Surprisingly, in facial cleansers, such ingredients also have the secondary effect of improving the foam quality to a fine and slick texture. The face wash of the present invention exhibits these two functions simultaneously. The preferable content of such components is preferably 1 to 5% by mass, more preferably 1.5 to 3% by mass, based on the total amount of the face wash.
(2)本発明の洗顔料
本発明の洗顔料は、前記必須成分を含有することを特徴とし、好ましい剤形としては、脂肪酸石鹸を洗浄剤とするものであって、クリーム状であることを特徴とする。前記石鹸としては、脂肪酸カリウム石鹸や脂肪酸ナトリウム石鹸が好ましく例示でき、脂肪酸カリウム石鹸を主たる洗浄剤とすることが好ましい。これは、脂肪酸カリウム石鹸から生じる泡と、(ビニルジメチコン/メチコンシルセスキオキサン)クロスポリマーの効果が著しいためである。従って、本発明の洗顔料の使用に際しては、手の平で、温水とともに良く泡立てて、泡だった泡を顔面に乗せて、この泡で小鼻を良く擦過することにより、小鼻に存する角栓を除去することができる。この際に(ビニルジメチコン/メチコンシルセスキオキサン)クロスポリマーの存在により、クリーム状の洗浄料に於いては、泡質が著しく向上する。泡立ちが改善されることにより、洗浄に伴う、皮膚に残存する洗顔料によって、誘導される刺激発現を防ぐことができる。又、界面活性能も、泡の形態を取ることにより、著しく向上するため、角栓除去効果も著しく向上する。従って、この様な使用態様で使用することが好ましい。泡の腰の強さは、角栓の存在状況により適宜強くも、弱くも調整することができる。
(2) Facial cleanser of the present invention The facial cleanser of the present invention is characterized by containing the above essential components, and as a preferred dosage form, fatty acid soap is used as a detergent, and it is creamy. Features. As the soap, fatty acid potassium soap and fatty acid sodium soap can be preferably exemplified, and fatty acid potassium soap is preferably used as a main cleaning agent. This is due to the remarkable effect of foams produced from fatty acid potassium soap and (vinyl dimethicone / methicone silsesquioxane) crosspolymer. Therefore, when using the face wash of the present invention, foam well with warm water in the palm of the hand, put the foam on the face and rub the nose well with this foam to remove the horn plugs present in the nose. be able to. At this time, the presence of the (vinyl dimethicone / methicone silsesquioxane) crosspolymer significantly improves the foam quality in creamy detergents. By improving foaming, it is possible to prevent irritation from being induced by the facial cleanser remaining on the skin. Moreover, since the surface active ability is remarkably improved by taking the form of bubbles, the effect of removing the plug is also remarkably improved. Therefore, it is preferable to use in such a use mode. The strength of the foam waist can be adjusted to be strong or weak as appropriate depending on the presence of the square plug.
本発明の洗顔料に於いては、炭素数6〜20二塩基酸のジエステルを好ましい成分として含有することを特徴とする。即ち、炭素数2〜10の二塩基酸と炭素数2〜6のアルキルジエステルを必須成分として含有する。ジエステルを構成するアルキル基は、それぞれ異なっても良く、同じでも良いが、同じであることがより好ましい。この様なジエステルの好ましいものとしては、例えば、酒石酸ジエチル、酒石酸ジイソプロピル、アジピン酸ジエチル、アジピン酸ジイソプロピル、セバシン酸ジエチル、セバシン酸ジイソプロピルなどが例示でき、セバシン酸ジイソプロピルが特に好ましく例示できる。これらは唯一種を含有することもできるし、二種以上を組み合わせて含有することもできる。又、かかる成分は、化粧料の汎用原料であり、その入手はたやすい。かかる成分は、本発明の洗顔料において、角栓の周囲及び角栓上部の強固な構造を脂質を溶解し、脂肪酸石鹸溶液に分散させることにより、毛穴より離脱させ、温水で除去しやすくする作用を有する。特に、角栓上部の脂質の構造をゆるめることにより、前記の球状の(ビニルジメチコン/メチコンシルセスキオキサン)クロスポリマー粉末との吸着性を高め、これが一種の浮きになって角栓が泡沫に吸着され離脱すると考えられる。この様な作用を発現するためには、総量で、洗顔料全量に対して、0.01〜10質量%含有することが好ましく、より好ましく、0.05〜1質量%である。これは少なすぎると前記の効果を奏さない場合が存し、多すぎると、製剤の脂肪酸石鹸の泡立ちを損なう場合が存するためである。 The facial cleanser of the present invention is characterized by containing a diester of 6 to 20 carbon diacids as a preferred component. That is, a dibasic acid having 2 to 10 carbon atoms and an alkyl diester having 2 to 6 carbon atoms are contained as essential components. The alkyl groups constituting the diester may be different or the same, but the same is more preferable. Preferred examples of such diesters include, for example, diethyl tartrate, diisopropyl tartrate, diethyl adipate, diisopropyl adipate, diethyl sebacate, diisopropyl sebacate, and diisopropyl sebacate is particularly preferred. These can contain only the seed | species, and can also contain it in combination of 2 or more type. Further, such components are general-purpose raw materials for cosmetics, and are easily available. In the face wash of the present invention, such a component has the effect of facilitating removal from the pores by dissolving the lipid in the solid structure around the square plug and the upper part of the square plug and dispersing it in the fatty acid soap solution, and removing it with warm water. Have In particular, by loosening the lipid structure at the top of the horn plug, it improves the adsorptivity with the spherical (vinyl dimethicone / methicone silsesquioxane) cross-polymer powder, which becomes a kind of floating and the horn plug becomes foamy. It is thought that it is adsorbed and detached. In order to express such an action, the total amount is preferably 0.01 to 10% by mass, more preferably 0.05 to 1% by mass with respect to the total amount of the face wash. This is because if the amount is too small, the above effect may not be achieved, and if the amount is too large, foaming of the fatty acid soap of the preparation may be impaired.
又、本発明の洗顔料に於いては、前記必須成分である球状の(ビニルジメチコン/メチコンシルセスキオキサン)クロスポリマー粉末以外に、ポリマー粉体を含有することもでき、この様なポリマー粉体を含有することにより、角栓の内の不溶性成分をより効率的に掻き取ることもできる。この様なポリマー粉体としては、球状のポリエチレン粉末が好ましく、前記ポリエチレン粉末の粒径としては、1〜1000μmが好ましく、5〜600μmがより好ましい。又、その形状は球状であることが好ましく、該球状とは、外接する真球よりプラスマイナス10%の最大歪みを許容する。この様なポリエチレン粉末としては、大小2種の粒度分布のものを組み合わせることが好ましく、該大の粒度分布としては、200〜600μmのものが好ましく例示でき、該小の粒度分布のものとしては、5〜15μmのものが好ましく例示できる。これらはこの大きさに分級したり、篩過して使用することもできるし、既にこのような粒度分布に揃えた市販品を購入して使用することもできる。この様な市販品としては、例えば、粒径が250〜500μmの「フロービーズ CL5007」(住友精化株式会社製)、粒径が5μmの「フロービーズ CL20200」(住友精化株式会社製)等が好ましく例示できる。この大小のポリエチレン粉末の質量比としては、25:1〜25:4が好ましい。かかる成分は、角栓を掻き出す作用と、角栓が毛穴より抜けるのを補助する作用を有すると思われる。(ビニルジメチコン/メチコンシルセスキオキサン)クロスポリマー粉末とは硬度が異なるため、(ビニルジメチコン/メチコンシルセスキオキサン)クロスポリマー粉末を可塑変形させて、より生体構造に適合した形で、スクラブ効果を奏することができる。この様な作用を発揮するためには、かかるポリエチレン粉末は、総量で、洗顔料全量に対して、0.1〜5質量%含有することが好ましく、0.1〜1.5質量%含有することがより好ましい。これは少なすぎると、前記効果を発揮しない場合が存し、多すぎても前記効果が頭打ちになり、前記二塩基酸のジエステルや球状の(ビニルジメチコン/メチコンシルセスキオキサン)クロスポリマー粉末の効果を損なう場合が存するためである。 In addition to the spherical (vinyl dimethicone / methicone silsesquioxane) cross-polymer powder, which is the essential component, the facial cleanser of the present invention may contain a polymer powder. By containing the body, it is possible to scrape insoluble components in the horn plug more efficiently. As such polymer powder, spherical polyethylene powder is preferable, and the particle size of the polyethylene powder is preferably 1-1000 μm, more preferably 5-600 μm. The shape is preferably spherical, and the spherical shape allows a maximum strain of plus or minus 10% from the circumscribed true sphere. As such polyethylene powder, it is preferable to combine two types of particle size distributions of large and small, and as the large particle size distribution, those having a particle size distribution of 200 to 600 μm can be preferably exemplified, The thing of 5-15 micrometers can be illustrated preferably. These can be classified to this size, or can be used after sieving, or commercially available products already having such a particle size distribution can be purchased and used. Examples of such commercially available products include “Flow Beads CL5007” (manufactured by Sumitomo Seika Co., Ltd.) having a particle size of 250 to 500 μm, “Flow Beads CL20200” (manufactured by Sumitomo Seika Co., Ltd.) having a particle size of 5 μm, and the like. Can be preferably exemplified. The mass ratio of the large and small polyethylene powders is preferably 25: 1 to 25: 4. Such a component seems to have an action of scraping the horn plug and an action of assisting the horn plug to come out of the pore. (Vinyl dimethicone / methicone silsesquioxane) Cross polymer powder has a different hardness, so (vinyl dimethicone / methicone silsesquioxane) cross polymer powder is plastically deformed to make it more suitable for anatomy and scrub effect Can be played. In order to exert such an action, the polyethylene powder is contained in a total amount of 0.1 to 5% by mass, preferably 0.1 to 1.5% by mass, based on the total amount of the face wash. It is more preferable. If the amount is too small, the above-mentioned effect may not be exhibited. If the amount is too large, the above-mentioned effect reaches a peak, and the diester of dibasic acid or the spherical (vinyl dimethicone / methicone silsesquioxane) cross-polymer powder. This is because the effect may be impaired.
又、本発明の洗顔料の剤形としては、通常洗顔料に使用されている剤形であれば、特段の限定無く適用することができ、前記通常洗顔料には、脂肪酸カリウム石鹸を主洗浄成分とするクリーム状の洗顔料、脂肪酸ナトリウム石鹸や、アシルグルタミン酸塩、両性界面活性剤、硫酸系アニオン界面活性剤などを主洗浄成分とする液状の洗顔料等が存するが、特に好ましくは、脂肪酸石鹸、取り分け、脂肪酸カリウム石鹸を主洗浄成分とするクリーム状の洗顔料に適用することが好ましい。好ましい形態における、前記脂肪酸カリウム石鹸の好ましい含有量は、脂肪酸を15〜25質量%、水酸化カリウムを6.5〜8.5質量%配合することによって形成される石鹸相当質量%である。この範囲以外では、角栓のウォッシュオフ効果を損なう場合が存する。 In addition, as the dosage form of the facial cleanser of the present invention, it can be applied without particular limitation as long as it is a dosage form that is usually used for facial cleansers. There are cream-type facial cleansers, fatty acid sodium soaps, acyl glutamates, amphoteric surfactants, and liquid facial cleansers mainly containing sulfuric anionic surfactants. It is preferable to apply to a cream-type facial cleanser having soap, especially, fatty acid potassium soap as a main cleaning component. The preferable content of the fatty acid potassium soap in a preferred form is a soap equivalent mass% formed by blending 15 to 25 mass% of fatty acid and 6.5 to 8.5 mass% of potassium hydroxide. Outside this range, there are cases where the washoff effect of the horn plug is impaired.
本発明の洗顔料においては、前記成分以外に、通常洗顔料で使用される任意成分を、本発明の効果の損なわれない範囲に於いて含有することができる。本発明の皮膚外用剤においては、かかる成分以外に、通常皮膚外用剤で使用される任意成分を含有することが出来る。この様な任意成分としては、例えば、マカデミアナッツ油、アボガド油、トウモロコシ油、オリーブ油、ナタネ油、ゴマ油、ヒマシ油、サフラワー油、綿実油、ホホバ油、ヤシ油、パーム油、液状ラノリン、硬化ヤシ油、硬化油、モクロウ、硬化ヒマシ油、ミツロウ、キャンデリラロウ、カルナウバロウ、イボタロウ、ラノリン、還元ラノリン、硬質ラノリン、ホホバロウ等のオイル、ワックス類;流動パラフィン、スクワラン、プリスタン、オゾケライト、パラフィン、セレシン、ワセリン、マイクロクリスタリンワックス等の炭化水素類;オレイン酸、イソステアリン酸、ラウリン酸、ミリスチン酸、パルミチン酸、ステアリン酸、ベヘン酸、ウンデシレン酸等の高級脂肪酸類;セチルアルコール、ステアリルアルコール、イソステアリルアルコール、ベヘニルアルコール、オクチルドデカノール、ミリスチルアルコール、セトステアリルアルコール等の高級アルコール等;イソオクタン酸セチル、ミリスチン酸イソプロピル、イソステアリン酸ヘキシルデシル、乳酸セチル、リンゴ酸ジイソステアリル、ジ−2−エチルヘキサン酸エチレングリコール、ジカプリン酸ネオペンチルグリコール、ジ−2−ヘプチルウンデカン酸グリセリン、トリ−2−エチルヘキサン酸グリセリン、トリ−2−エチルヘキサン酸トリメチロールプロパン、トリイソステアリン酸トリメチロールプロパン、テトラ−2−エチルヘキサン酸ペンタンエリトリット等の合成エステル油類;ジメチルポリシロキサン、メチルフェニルポリシロキサン、ジフェニルポリシロキサン等の鎖状ポリシロキサン;オクタメチルシクロテトラシロキサン、デカメチルシクロペンタシロキサン、ドデカメチルシクロヘキサンシロキサン等の環状ポリシロキサン;アミノ変性ポリシロキサン、ポリエーテル変性ポリシロキサン、アルキル変性ポリシロキサン、フッ素変性ポリシロキサン等の変性ポリシロキサン等のシリコーン油等の油剤類;ラウリル硫酸カリウム、アルキル硫酸トリエタノールアミンエーテル等のアニオン界面活性剤類;塩化ステアリルトリメチルアンモニウム、塩化ベンザルコニウム、ラウリルアミンオキサイド等のカチオン界面活性剤類;イミダゾリン系両性界面活性剤(2−ココイル−2−イミダゾリニウムヒドロキサイド−1−カルボキシエチロキシ2ナトリウム塩等)、ベタイン系界面活性剤(アルキルベタイン、アミドベタイン、スルホベタイン等)、アシルメチルタウリン等の両性界面活性剤類;ソルビタン脂肪酸エステル類(ソルビタンモノステアレート、セスキオレイン酸ソルビタン等)、グリセリン脂肪酸類(モノステアリン酸グリセリン等)、プロピレングリコール脂肪酸エステル類(モノステアリン酸プロピレングリコール等)、硬化ヒマシ油誘導体、グリセリンアルキルエーテル、POEソルビタン脂肪酸エステル類(POEソルビタンモノオレエート、モノステアリン酸ポリオキエチレンソルビタン等)、POEソルビット脂肪酸エステル類(POE−ソルビットモノラウレート等)、POEグリセリン脂肪酸エステル類(POE−グリセリンモノイソステアレート等)、POE脂肪酸エステル類(ポリエチレングリコールモノオレート、POEジステアレート等)、POEアルキルエーテル類(POE2−オクチルドデシルエーテル等)、POEアルキルフェニルエーテル類(POEノニルフェニルエーテル等)、プルロニック型類、POE・POPアルキルエーテル類(POE・POP2−デシルテトラデシルエーテル等)、テトロニック類、POEヒマシ油・硬化ヒマシ油誘導体(POEヒマシ油、POE硬化ヒマシ油等)、ショ糖脂肪酸エステル、アルキルグルコシド等の非イオン界面活性剤類;ポリエチレングリコール、グリセリン、1,3−ブチレングリコール、エリスリトール、ソルビトール、キシリトール、マルチトール、プロピレングリコール、ジプロピレングリコール、ジグリセリン、イソプレングリコール、1,2−ペンタンジオール、2,4−ヘキサンジオール、1,2−ヘキサンジオール、1,2−オクタンジオール等の多価アルコール類;ピロリドンカルボン酸ナトリウム、乳酸、乳酸ナトリウム等の保湿成分類;表面を処理されていても良い、マイカ、タルク、カオリン、合成雲母、炭酸カルシウム、炭酸マグネシウム、無水ケイ酸(シリカ)、酸化アルミニウム、硫酸バリウム等の粉体類、;表面を処理されていても良い、ベンガラ、黄酸化鉄、黒酸化鉄、酸化コバルト、群青、紺青、酸化チタン、酸化亜鉛の無機顔料類;表面を処理されていても良い、雲母チタン、魚燐箔、オキシ塩化ビスマス等のパール剤類;レーキ化されていても良い赤色202号、赤色228号、赤色226号、黄色4号、青色404号、黄色5号、赤色505号、赤色230号、赤色223号、橙色201号、赤色213号、黄色204号、黄色203号、青色1号、緑色201号、紫色201号、赤色204号等の有機色素類;ポリメタクリル酸メチル、ナイロン粉末、オルガノポリシロキサンエラストマー等の有機粉体類;パラアミノ安息香酸系紫外線吸収剤;アントラニル酸系紫外線吸収剤;サリチル酸系紫外線吸収剤、;桂皮酸系紫外線吸収剤、;ベンゾフェノン系紫外線吸収剤;糖系紫外線吸収剤;2−(2’−ヒドロキシ−5’−t−オクチルフェニル)ベンゾトリアゾール、4−メトキシ−4’−t−ブチルジベンゾイルメタン等の紫外線吸収剤類;エタノール、イソプロパノール等の低級アルコール類;ビタミンA又はその誘導体、ビタミンB6塩酸塩、ビタミンB6トリパルミテート、ビタミンB6ジオクタノエート、ビタミンB2又はその誘導体、ビタミンB12、ビタミンB15又はその誘導体等のビタミンB類;α−トコフェロール、β−トコフェロール、γ−トコフェロール、ビタミンEアセテート等のビタミンE類、ビタミンD類、ビタミンH、パントテン酸、パンテチン、ピロロキノリンキノン等のビタミン類等;フェノキシエタノール等の抗菌剤などが好ましく例示できる。 In the face wash of the present invention, in addition to the above-mentioned components, optional components that are usually used in face wash can be contained within a range that does not impair the effects of the present invention. The external preparation for skin of the present invention can contain, in addition to such components, optional components that are usually used in external preparations for skin. Such optional ingredients include, for example, macadamia nut oil, avocado oil, corn oil, olive oil, rapeseed oil, sesame oil, castor oil, safflower oil, cottonseed oil, jojoba oil, coconut oil, palm oil, liquid lanolin, hydrogenated coconut oil Oil, wax, oil such as beeswax, canola wax, carnauba wax, ibotarou, lanolin, reduced lanolin, hard lanolin, jojoba wax, liquid paraffin, squalane, pristane, ozokerite, paraffin, ceresin, petrolatum , Hydrocarbons such as microcrystalline wax; higher fatty acids such as oleic acid, isostearic acid, lauric acid, myristic acid, palmitic acid, stearic acid, behenic acid, undecylenic acid; cetyl alcohol, stearyl alcohol, isostearyl Higher alcohols such as alcohol, behenyl alcohol, octyldodecanol, myristyl alcohol, cetostearyl alcohol; cetyl isooctanoate, isopropyl myristate, hexyldecyl isostearate, cetyl lactate, diisostearyl malate, ethylene di-2-ethylhexanoate Glycol, neopentyl glycol dicaprate, glycerin di-2-heptylundecanoate, glycerin tri-2-ethylhexanoate, trimethylolpropane tri-2-ethylhexanoate, trimethylolpropane triisostearate, tetra-2-ethylhexane Synthetic ester oils such as acid pentane erythritol; chain polysiloxanes such as dimethylpolysiloxane, methylphenylpolysiloxane, and diphenylpolysiloxane; Cyclic polysiloxanes such as kutamethylcyclotetrasiloxane, decamethylcyclopentasiloxane, and dodecamethylcyclohexanesiloxane; silicones such as amino-modified polysiloxane, polyether-modified polysiloxane, alkyl-modified polysiloxane, and fluorine-modified polysiloxane Oils such as oils; Anionic surfactants such as potassium lauryl sulfate and alkylethanol triethanolamine ether; Cationic surfactants such as stearyltrimethylammonium chloride, benzalkonium chloride and laurylamine oxide; Imidazoline-based amphoteric surfactants Agents (2-cocoyl-2-imidazolinium hydroxide-1-carboxyethyloxy disodium salt, etc.), betaine surfactants (alkyl betaines, amide betaines, Amphoteric surfactants such as sulfobetaine), acylmethyltaurine, etc .; sorbitan fatty acid esters (such as sorbitan monostearate, sorbitan sesquioleate), glycerin fatty acids (such as glyceryl monostearate), propylene glycol fatty acid esters ( Propylene glycol monostearate), hardened castor oil derivative, glycerin alkyl ether, POE sorbitan fatty acid esters (POE sorbitan monooleate, polyoxyethylene sorbitan monostearate, etc.), POE sorbite fatty acid esters (POE-sorbit monolaur) POE glycerin fatty acid esters (POE-glycerin monoisostearate, etc.), POE fatty acid esters (polyethylene glycol monooleate, POE diste) Rate), POE alkyl ethers (POE2-octyldodecyl ether, etc.), POE alkylphenyl ethers (POE nonylphenyl ether, etc.), Pluronic types, POE / POP alkyl ethers (POE / POP2-decyltetradecyl ether, etc.) ), Tetronics, POE castor oil / hardened castor oil derivatives (POE castor oil, POE hardened castor oil, etc.), nonionic surfactants such as sucrose fatty acid ester, alkyl glucoside; polyethylene glycol, glycerin, 1, 3 -Butylene glycol, erythritol, sorbitol, xylitol, maltitol, propylene glycol, dipropylene glycol, diglycerin, isoprene glycol, 1,2-pentanediol, 2,4-hexanediol, 1 Polyhydric alcohols such as 2-hexanediol and 1,2-octanediol; moisturizing ingredients such as sodium pyrrolidonecarboxylate, lactic acid, sodium lactate; mica, talc, kaolin, synthetic mica whose surface may be treated , Powders such as calcium carbonate, magnesium carbonate, anhydrous silicic acid (silica), aluminum oxide, barium sulfate; surface may be treated, bengara, yellow iron oxide, black iron oxide, cobalt oxide, ultramarine, Inorganic pigments of bitumen, titanium oxide, zinc oxide; pearl agents such as titanium mica, fish phosphorus foil, bismuth oxychloride, which may be treated on the surface; red 202, red 228, which may be raked No., Red 226, Yellow No. 4, Blue No. 404, Yellow No. 5, Red No. 505, Red No. 230, Red No. 223, Orange No. 201, Red No. 213 No., Yellow No. 204, Yellow No. 203, Blue No. 1, Green No. 201, Purple No. 201, Red No. 204, etc .; Organic powders such as polymethyl methacrylate, nylon powder, organopolysiloxane elastomer; Paraaminobenzoic acid UV absorbers; Anthranilic acid UV absorbers; Salicylic acid UV absorbers; Cinnamic acid UV absorbers; Benzophenone UV absorbers; Sugar UV absorbers; 2- (2'-hydroxy- UV absorbers such as 5'-t-octylphenyl) benzotriazole and 4-methoxy-4'-t-butyldibenzoylmethane; lower alcohols such as ethanol and isopropanol; vitamin A or a derivative thereof, vitamin B6 hydrochloride , Vitamin B6 tripalmitate, vitamin B6 dioctanoate, vitamin B2 or its derivatives Vitamin B such as vitamin B12, vitamin B15 or derivatives thereof; α-tocopherol, β-tocopherol, γ-tocopherol, vitamin E such as vitamin E acetate, vitamin D, vitamin H, pantothenic acid, panthetin, pyrroloquinoline quinone Preferred examples include vitamins such as; antibacterial agents such as phenoxyethanol.
本発明の洗顔料は、前記必須成分、好ましい成分、任意成分を常法に従って処理することにより製造することができる。斯くして得られた洗顔料は、洗浄により、小鼻に蓄積した角栓を除去することができる。 The face wash of the present invention can be produced by treating the essential components, preferred components, and optional components according to a conventional method. The facial cleanser thus obtained can remove horn plugs accumulated in the small nose by washing.
以下に、実施例をあげて、本発明について、更に詳細に説明を加えるが、本発明がかかる実施例にのみ限定されないことは言うまでもない。 Hereinafter, the present invention will be described in more detail with reference to examples, but it is needless to say that the present invention is not limited to such examples.
以下に示す処方に従って、本発明の洗顔料を製造した。即ち、イ、ロの成分をそれぞれ90℃に加温し、攪拌下イにロを徐々に添加し、これにハを加え分散した後、攪拌冷却して洗顔料1を得た。同時に「シリコーンKSP−102」を「フロービーズ CL5007」に置換した比較例1、ステアリン酸、ミリスチン酸、ラウリン酸及び水酸化カリウムをPOE(3)ラウリル硫酸ナトリウムに置換した洗顔料2も同様に作成した。 The face wash of the present invention was produced according to the formulation shown below. That is, the components (a) and (b) were each heated to 90 ° C., and (b) was gradually added to (a) while stirring. At the same time, Comparative Example 1 in which “Silicone KSP-102” was replaced with “Flow Beads CL5007”, Facial wash 2 in which stearic acid, myristic acid, lauric acid and potassium hydroxide were replaced with POE (3) sodium lauryl sulfate were similarly prepared. did.
<試験例1>
上記洗顔料1、比較例1及び洗顔料2について、パネラー1群5名、3群15名を使用し、角栓の除去効果を調べた。即ち、パネラーの小鼻をモリテックス株式会社製の「ビデオマイクロスコープ」で撮影し、1視野あたりの角栓の蓄積数を計数した。しかる後にサンプルを用いて洗顔を行い、洗顔後10分に再び「ビデオマイクロスコープ」で撮影し、1視野あたりの角栓の蓄積数を計数した。洗顔後の角栓蓄積数を、洗顔前の角栓蓄積数で除し、100を乗じて角栓残存率を算出した。結果を表2に示す。これより、本発明の洗顔料は角栓除去作用に優れることがわかる。尚、洗浄は予めネットで洗顔料を泡立て、これを顔面に塗布し、まんべんなく4回手で擦過し、しかる後に顔全面に2分間シャワーで温水をかけて流す形で行った。
<Test Example 1>
About the said face wash 1, comparative example 1, and face wash 2, the paneler 1 group 5 persons and 3 groups 15 persons were used, and the removal effect of a square plug was investigated. That is, the nose of the panel was photographed with a “video microscope” manufactured by Moritex Co., Ltd., and the number of accumulated square plugs per field of view was counted. After that, the sample was used to wash the face, and 10 minutes after the face was washed again with a “video microscope”, and the number of accumulated square plugs per field of view was counted. The number of accumulated plugs after washing was divided by the number of accumulated plugs before washing, and multiplied by 100 to calculate the remaining rate of plugs. The results are shown in Table 2. From this, it can be seen that the face wash of the present invention is excellent in the action of removing the plug. Washing was performed by foaming face wash with a net in advance, applying it onto the face, rubbing it evenly by hand four times, and then pouring warm water over the entire face for 2 minutes with a shower.
<試験例2>
シリコーンラバー板にマント針を装着した注射筒を用いて深さ1.5mmの深度でケラチンパウダーとヒマシ油の4:1の質量比の混合物を40個埋め込んだものを2つ作成した。これを小鼻モデルとし、角栓除去試験を行った。1つは洗顔料1を泡立てた泡を塗布し、手で4回擦過し、2分間温水を流す処置を行い、1つは市販の角栓除去シートを貼付して剥がす処置を行った。処置後、ラバー板をヨウ素蒸気に5分間当てて、その注入孔の着色度合いを比較したところ、有意に洗顔料1による処置の方が薄く、洗顔料1によれば角栓除去のみならず、毛穴の洗浄もできることが明らかになった。
<Test Example 2>
Two syringes each embedded with 40 mixtures of a 4: 1 mass ratio of keratin powder and castor oil at a depth of 1.5 mm were prepared using a syringe barrel equipped with a cloak needle on a silicone rubber plate. Using this as a small nose model, a horn plug removal test was conducted. One was applied with foamed facial cleanser 1 and rubbed by hand 4 times, and the warm water was allowed to flow for 2 minutes, and the other was applied with a commercially available square plug removal sheet. After the treatment, the rubber plate was exposed to iodine vapor for 5 minutes, and the coloring degree of the injection hole was compared. As a result, the treatment with the face wash 1 was significantly thinner. It became clear that pores could be washed.
次の表3に示す処方に従って、本発明の洗顔料である、洗顔料3〜5を洗顔料1と同様に製造した。試験例1の方法での評価結果を表4に示す。これより、本発明の洗顔料は、優れた角栓除去作用を有することがわかる。 In accordance with the formulation shown in Table 3 below, face wash 3-5, which are the face wash of the present invention, were produced in the same manner as face wash 1. Table 4 shows the evaluation results obtained by the method of Test Example 1. From this, it can be seen that the face wash of the present invention has an excellent action for removing keratin plugs.
次の表5に示す処方に従って、本発明の洗顔料である、洗顔料6〜8を洗顔料1と同様に製造した。試験例1の方法での評価結果を表6に示す。これより、本発明の洗顔料は、優れた角栓除去作用を有することがわかる。 According to the formulation shown in the following Table 5, face wash 6 to 8, which are the face wash of the present invention, were produced in the same manner as face wash 1. Table 6 shows the evaluation results obtained by the method of Test Example 1. From this, it can be seen that the face wash of the present invention has an excellent action for removing keratin plugs.
次の表7に示す処方に従って、本発明の洗顔料である、洗顔料9を洗顔料1と同様に製造した。角栓残存率は10.2±8.6%であった。このものを洗顔料1、比較例1、洗顔料6〜8とともに泡立て試験に付した。泡立て試験は、サンプル1gに500mLの水を加え、ミキサーで3分混合し、メスシリンダーへ移して、直後と30分後に泡の体積を計測し行った。結果を表8に示す。これらのデータより、ポリエチレン粉末が存在した方が角栓除去の面でも、泡立ちの面でも好ましいことがわかる。 In accordance with the formulation shown in Table 7 below, face wash 9 as a face wash of the present invention was produced in the same manner as face wash 1. The residual plug rate was 10.2 ± 8.6%. This was subjected to a foaming test together with face wash 1, comparative example 1, face wash 6-8. In the foaming test, 500 mL of water was added to 1 g of the sample, mixed for 3 minutes with a mixer, transferred to a graduated cylinder, and the volume of the foam was measured immediately and 30 minutes later. The results are shown in Table 8. From these data, it can be seen that the presence of the polyethylene powder is preferable both in terms of removal of square plugs and in terms of foaming.
本発明は、洗顔料に応用できる。 The present invention can be applied to a face wash.
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2006173218A JP2008001643A (en) | 2006-06-23 | 2006-06-23 | Horny plug-removing facial cleansing agent |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2006173218A JP2008001643A (en) | 2006-06-23 | 2006-06-23 | Horny plug-removing facial cleansing agent |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2008001643A true JP2008001643A (en) | 2008-01-10 |
Family
ID=39006327
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2006173218A Pending JP2008001643A (en) | 2006-06-23 | 2006-06-23 | Horny plug-removing facial cleansing agent |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2008001643A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2018009020A (en) * | 2012-03-05 | 2018-01-18 | 大塚製薬株式会社 | Sunscreen composition |
-
2006
- 2006-06-23 JP JP2006173218A patent/JP2008001643A/en active Pending
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2018009020A (en) * | 2012-03-05 | 2018-01-18 | 大塚製薬株式会社 | Sunscreen composition |
US10925813B2 (en) | 2012-03-05 | 2021-02-23 | Otsuka Pharmaceutical Co., Ltd. | Sunscreen composition |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2007230929A (en) | Face wash for removing horny plug | |
JP2008019230A5 (en) | ||
JP2008297238A5 (en) | ||
JP2007131585A (en) | Aerosol preparation-form cleansing cosmetic | |
JP5057808B2 (en) | Skin external preparation with excellent moisture retention | |
JP2007302611A (en) | Facial cleanser | |
JPH11263721A (en) | Oil-in-water type gommage (peeling) cosmetic | |
JP5368005B2 (en) | Skin external preparation with cleansing function | |
JP2007297351A5 (en) | ||
JP4734108B2 (en) | Cleansing oil | |
JP2008001643A (en) | Horny plug-removing facial cleansing agent | |
JP2007191406A5 (en) | ||
JP2004224726A (en) | Cleansing cosmetic composition | |
JP2007302611A5 (en) | ||
JP5069940B2 (en) | Emulsifier type skin external preparation | |
JP2007119393A5 (en) | ||
JP2007161626A (en) | Detergent for sensitive skin | |
JP5916993B2 (en) | Amino acid elution inhibitor | |
JP2007161627A5 (en) | ||
JP2008001644A (en) | Gel cosmetic | |
JP5068097B2 (en) | Emulsifier type skin external preparation | |
JP2005068084A (en) | Foam-like cleaning agent | |
JP4881040B2 (en) | Gel cosmetic | |
JP5276770B2 (en) | Cosmetics for wrinkle removal massage | |
JP4871624B2 (en) | Cosmetics for softening the skin |